Massively Parallel Sequencing in Biopharmaceutical QC Testing – Is it too much information?

13th May 2011

Category: Biosafety

Tags: , ,

By: Dr Daniel Galbraith, CSO

There is a tendency towards conservatism utilising tried and tested methodologies in the safety and QC testing schemes designed for biopharmaceuticals, rightly so. In the early 1990s PCR was a useful research tool and was beginning to be used in targeted adventitious agent testing in cell lines and products, particularly virus vaccines, because of its More

Sign-up to receive 3 tips on improving
speed to clinic for biosimilars

Sign-up to receive 3 tips on improving
speed to clinic for biosimilars

* you agree to receive emails with tips, news, insights and quizzes.